Overdose deaths hit another record

A new federal report also shows signs that the country's overdose rate may finally be leveling off after years of steady increase.

March 21, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | U.K. health officials and researchers try to carve a path for more individualized genetic treatments No individualized treatment has been designed and given to a patient in the U.K. yet, but advocates say they see an opportunity in the country. By Andrew Joseph STAT+ | Gene-edited pig kidney transplanted into a living patient for the first time The company behind the engineered pig kidney is eGenesis, which has pioneered the making of human-friendly pig parts using CRISPR. By Megan Molteni and Eric Boodman Overdose deaths hit another record but show signs of leveling off The flattening of drug death rates could provide a rare glimmer of hope amid the long U.S. opioid addiction crisis. By Lev Facher Adobe STAT+ | Digital tools for diabetes management did not deliver benefits that justify cost, new report finds Digital diabetes tools from companies like Teladoc and Omada "do not deliver clinical benefits that justify their cost," an analysis found. By Katie Palmer and Mario Aguilar STAT+ | Ibogaine, the psychedelic, unlikely to receive approval as opioid treatment, says top addiction researcher Ibogaine's cardiac toxicity makes FDA approval unlikely as a treatment of opioid disorder, Nora Volkow says at the STAT Breakthrough Summit. By Lev Facher STAT+ | Regeneron's plot to 'cure' allergies At STAT Breakthrough Summit, Regeneron's George Yancopoulos discusses new allergy treatments, better weight loss drugs, and his high school science project. By Damian Garde Molly Ferguson/STAT STAT+ | A preview of Intra-Cellular Therapies' depression drug, and sizing up the MASH opportunity This week: A preview of Intra-Cellular Therapies' depression drug study, and a couple of liver-disease physician perspectives on Rezdiffra. By Adam Feuerstein Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help? STAT Breakthrough Summit: Lifesaving CRISPR gene editing technology needs new tests, processes, and infrastructure to expand use of personalized medicine. By Annalisa Merelli

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser